Insilico Medicine's AI-designed drug shows promise in treating pulmonary fibrosis. Enveda's AI-driven approach targets dermatitis. FDA approvals, partnerships, and investments in healthcare innovation are on the rise. Research on GLP-1 drugs' effects on alcohol use disorder yields promising results.